新生儿和婴儿心脏术后静脉吗啡与静脉对乙酰氨基酚比较:随机对照试验研究方案
本研究为在荷兰和比利时4个三级儿科ICU开展的前瞻性多中心随机对照试验,计划纳入0-36月龄心脏术后患儿208例,随机接受间歇静脉对乙酰氨基酚或持续静脉吗啡至术后48小时,两组均以吗啡为补救镇痛。主要目的是检验对乙酰氨基酚可减少至少30%累积吗啡用量的假设,样本量按双侧显著性5%、把握度95%计算。
要点
- 0-36月龄心脏术后患儿随机接受静脉对乙酰氨基酚或持续吗啡,吗啡为两组补救用药。
- 主要假设为对乙酰氨基酚组累积吗啡用量减少至少30%,样本量208例(每组104例)。
- 研究结果拟用于制定参与ICU的术后疼痛管理算法和循证指南。
核心结论
- 研究旨在验证心脏术后婴幼儿间歇静脉对乙酰氨基酚可减少至少30%累积吗啡用量的假设,结果尚未报告。
研究设计与样本
- 前瞻性、多中心、随机对照试验,在荷兰和比利时4个三级儿科ICU开展。
- 计划纳入0-36月龄心脏术后患儿208例,每组104例,随机接受间歇静脉对乙酰氨基酚或持续静脉吗啡至术后48小时。
- 样本量按检测30%吗啡剂量减少计算,双侧显著性水平5%,把握度95%。
关键数值与推荐
- 主要终点为累积吗啡用量减少至少30%。
- 两组均以吗啡作为补救镇痛药物,并使用验证过的疼痛和镇静评估工具监测。
- 试验注册号NTR5448,伦理批件MEC2015-646,当前方案版本2017年7月3日。
临床怎么用
- 研究结果拟作为参与ICU术后疼痛管理算法的基础,并形成0-36月龄婴儿心脏术后疼痛的循证指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Morphine is worldwide the analgesic of first choice after cardiac surgery in children. Morphine has unwanted hemodynamic and respiratory side effects. Therefore, post-cardiac surgery patients may potentially benefit from a non-opioid drug for pain relief. A previous study has shown that intravenous (IV) paracetamol is effective and opioid-sparing in children after major non-cardiac surgery. The aim of the study is to test the hypothesis that intermittent IV paracetamol administration in children after cardiac surgery will result in a reduction of at least 30% of the cumulative morphine requirement. METHODS: This is a prospective, multi-center, randomized controlled trial at four level-3 pediatric intensive care units (ICUs) in the Netherlands and Belgium. Children who are 0-36 months old will be randomly assigned to receive either intermittent IV paracetamol or continuous IV morphine up to 48 h post-operatively. Morphine will be available as rescue medication for both groups. Validated pain and sedation assessment tools will be used to monitor patients. The sample size (n = 208, 104 per arm) was calculated in order to detect a 30% reduction in morphine dose; two-sided significance level was 5% and power was 95%. DISCUSSION: This study will focus on the reduction, or replacement, of morphine by IV paracetamol in children (0-36 months old) after cardiac surgery. The results of this study will form the basis of a new pain management algorithm and will be implemented at the participating ICUs, resulting in an evidence-based guideline on post-operative pain after cardiac surgery in infants who are 0-36 months old. TRIAL REGISTRATION: Dutch Trial Registry ( www.trialregister.nl ): NTR5448 on September 1, 2015. Institutional review board approval (MEC2015-646), current protocol version: July 3, 2017.
引用
- Zeilmaker-Roest GA, van Rosmalen J, van Dijk M, et al. Intravenous morphine versus intravenous paracetamol after cardiac surgery in neonates and infants: a study protocol for a randomized controlled trial. Trials. 2018. PMID: 29895289. doi:10.1186/s13063-018-2705-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。